GENEVA, Sept. 7 -- THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA filed a patent application (US2026/017010) for “COMBINATION IMMUNOTHERAPY OF STEAP2-CART CELLS DELIVERING ANTI-CD28 BISPECIFICS TARGETING PSMA”. With publication no. WO/2026/183426, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C07K 14/705
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....